Ganesh Swaminathan
Principal Scientist Pfizer
Ganesh Swaminathan is a Principal Scientist at Pfizer, where he leads innovative approaches to target identification, screening, and preclinical assay development. With prior leadership roles at Novartis Institutes for BioMedical Research and GNF, he has extensive experience building and managing automated, cost‑effective cell‑based platforms for drug discovery and safety assessment. Ganesh brings deep expertise in complex in vitro and ex vivo disease models across kidney, lung, GI, liver, CNS, and tumor biology. He completed postdoctoral training at Stanford and Rice University, focusing on stem cell therapies, 3D organoid models, and translational research to accelerate therapeutic development
Seminars
While first-in-human trials remain the ultimate test, this workshop focuses on how to de-risk programs earlier. It tackles the critical industry challenge of poor translation by moving beyond standard animal models to validate new in vitro systems and design smarter, more predictive non-clinical packages. Attend this workshop to improve the probability of clinical success by:
- Evaluating the predictive value of organoids, microphysiological systems, and computational models against historical clinical data for known toxicities like ILD and ocular toxicity.
- Developing a framework for reverse translation, using clinical safety signals to refine and calibrate preclinical models for better future predictions.
- Navigating the FDA’s NAMs initiative. Discussing practical strategies for implementing New Approach Methodologies and preparing robust data packages to support regulatory submissions with reduced reliance on animal studies.
